Main Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Name: Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
Rating: 5.0 (4 reviews)

Casadei-Gardini, Andrea (author);Rimini, Margherita (author);Tada, Toshifumi (author);Suda, Goki (author);Shimose, Shigeo (author);Kudo, Masatoshi (author);Cheon, Jaekyung (author);Finkelmeier, Fabian (author);Lim, Ho Yeong (author);Rimassa, Lorenza (auth

5.0 / 5.0

0 comments

Download Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population book for free from OceanOfPDF

Request Code : ZLIB.IO17852217

Categories:

Year:

2022

Publisher:

Elsevier BV

Language:

English